[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $gyre Gyre sees increased community engagement with positive reactions to recent updates. Market volatility causes price fluctuations, but the overall sentiment remains cautiously optimistic. ### About $gyre A cryptocurrency project. ### Insights [#](/topic/$gyre/insights) - $gyre creators is up XXX% from the previous week. - $gyre engagements is up XXXXX% from the previous week. - $gyre mentions is up XXX% from the previous week. ### Engagements: XXX [#](/topic/$gyre/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$gyre/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXXXX **1 Week**: XXXXX +93% **1 Month**: XXXXX +6.50% **1-Year High**: XXXXXX on 2025-05-23 **1-Year Low**: X on 2025-09-16 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: X [#](/topic/$gyre/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$gyre/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: XX **1 Week**: XX +400% **1 Month**: XX +100% **1-Year High**: XXX on 2025-07-07 **1-Year Low**: X on 2025-04-27 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: X [#](/topic/$gyre/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$gyre/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $gyre in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1 Week**: X +350% **1 Month**: XX +175% **1-Year High**: XXX on 2025-07-07 **1-Year Low**: X on 2025-04-27 The most influential creators that mention $gyre in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XXX | [View More](/list/creators/$gyre/100) ### Sentiment: XXX% [#](/topic/$gyre/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$gyre/time-series/sentiment.tsv) **Current Value**: XXX% **Daily Average**: XX% **1 Month**: XXX% no change **1-Year High**: XXX% on 2025-05-13 **1-Year Low**: X% on 2025-09-21 **Most Supportive Themes** - **Community Engagement:** (45%) Positive sentiment around project updates and community involvement. - **Technological Advancements:** (20%) Enthusiasm for new features and technological progress. **Most Critical Themes** - **Market Volatility:** (15%) Concerns about price fluctuations and market uncertainty. - **Competition:** (10%) Discussion of competing projects and their potential impact. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | XX% | XXX | XX% | X | X% | | | | | | | | | | Total | XXX | XX% | XXX | XX% | X | X% | **Top assets mentioned** In the posts about $gyre in the last XX hours [Sora (SORA)](/topic/$sora) [Abbott Laboratories (ABT)](/topic/abbott-laboratories) [Arcblock (ABT)](/topic/$abt) [Aptiv PLC (APTV)](/topic/aptiv-plc) [Veritaseum (VERI)](/topic/$veri) [Novo-Nordisk (NVO)](/topic/$nvo) [GSK plc (GSK)](/topic/gsk-plc) [MP Materials Corp. (MP)](/topic/$mp) [Acuren Corporation (TIC)](/topic/$tic) **Top topics mentioned** In the posts about $gyre in the last XX hours [$omer](/topic/$omer), [stocks healthcare](/topic/stocks-healthcare), [alternative investment](/topic/alternative-investment), [$aplm](/topic/$aplm), [$sprc](/topic/$sprc), [$sora](/topic/$sora), [coins meme](/topic/coins-meme), [$feam](/topic/$feam), [$codi](/topic/$codi), [abbott laboratories](/topic/abbott-laboratories), [$abt](/topic/$abt), [aptiv plc](/topic/aptiv-plc), [chronic](/topic/chronic), [runner](/topic/runner), [acquisition](/topic/acquisition), [sleeper](/topic/sleeper), [$kros](/topic/$kros), [$veri](/topic/$veri), [$tgen](/topic/$tgen), [$sana](/topic/$sana), [coins base ecosystem](/topic/coins-base-ecosystem), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$nvo](/topic/$nvo), [$scyx](/topic/$scyx), [gsk plc](/topic/gsk-plc), [$qnrx](/topic/$qnrx), [$ptle](/topic/$ptle), [$gwh](/topic/$gwh), [$sgbx](/topic/$sgbx), [market cap](/topic/market-cap), [$72752m](/topic/$72752m), [news on](/topic/news-on), [stocks utilities](/topic/stocks-utilities), [$mp](/topic/$mp), [stocks industrials](/topic/stocks-industrials), [stocks financial services](/topic/stocks-financial-services), [$tic](/topic/$tic), [stocks](/topic/stocks) ### Top Social Posts [#](/topic/$gyre/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "100new $OMER $VERI $TGEN $SANA $BTDR $SERV $CEPU $PZZA $AIRJ $PHAT $SLN $GYRE $ARRY $OUST $AEVA $ALMU $LEU $ASM $PLPC $ABSI $UEC $ASTL $HI $SSTK $ICHR $MANU $NXT $AQST $BZAI $LTBR $AMPX" [X Link](https://x.com/MammaaiutoY/status/1978733794674053476) [@MammaaiutoY](/creator/x/MammaaiutoY) 2025-10-16T08:04Z XXX followers, XXX engagements "🧬 Biotech Stock News 10/15 Brought to you by Barb On the rise 📈 $OMER XXX% $APLM XX% $SPRC XX% Under pressure 📉 $KROS -X% $EYPT -X% $AKTX -XX% Catch the full breakdown in the latest video" [X Link](https://x.com/BiopharmIQ/status/1978513110827761733) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-15T17:27Z 27.5K followers, 3810 engagements "$GYRE Gyre Therapeutics shares are trading higher after the company announced it completed patient enrollment in the Phase X clinical trial of Pirfenidone capsules for the treatment of pneumoconiosis" [X Link](https://x.com/stocknear/status/1978491744057483513) [@stocknear](/creator/x/stocknear) 2025-10-15T16:02Z XXX followers, XXX engagements "📣 Biotech Stock News 10/15 @ Open $OMER XXX% Asset purchase & license agreement $APLM XX% Resumes Trading $SPRC XX% Acquisition Agreement $ABSI XX% KOL Seminar on ABS-201 Program $XNCR X% Ph1 Dose-Escalation Results Presented $GYRE X% Completion of Patient Enrollment in Trial $SCYX X% Disagreement Resolved on Phase X Study $NVCR X% New Research for TTFields Therapy $HIMS X% Launches Menopause & Perimenopause Specialty $TEM X% Six Abstracts Accepted for ESMO 2025 $MNPR X% Abstract Accepted for Oral Presentation $ACOG X% Presenting Clinical Data at Meetings $AUPH X% Upcoming Presentations on" [X Link](https://x.com/BiopharmIQ/status/1978486736369123644) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-15T15:42Z 27.4K followers, 9650 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Gyre sees increased community engagement with positive reactions to recent updates. Market volatility causes price fluctuations, but the overall sentiment remains cautiously optimistic.
A cryptocurrency project.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX +93%
1 Month: XXXXX +6.50%
1-Year High: XXXXXX on 2025-05-23
1-Year Low: X on 2025-09-16
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
1 Week: XX +400%
1 Month: XX +100%
1-Year High: XXX on 2025-07-07
1-Year Low: X on 2025-04-27
Social Network | X |
---|---|
Mentions | XX |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $gyre in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: X +350%
1 Month: XX +175%
1-Year High: XXX on 2025-07-07
1-Year Low: X on 2025-04-27
The most influential creators that mention $gyre in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@BiopharmIQ | X | XXXXXX | X | XXX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Month: XXX% no change
1-Year High: XXX% on 2025-05-13
1-Year Low: X% on 2025-09-21
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXX | XX% | XXX | XX% | X | X% |
Total | XXX | XX% | XXX | XX% | X | X% |
Top assets mentioned In the posts about $gyre in the last XX hours
Sora (SORA) Abbott Laboratories (ABT) Arcblock (ABT) Aptiv PLC (APTV) Veritaseum (VERI) Novo-Nordisk (NVO) GSK plc (GSK) MP Materials Corp. (MP) Acuren Corporation (TIC)
Top topics mentioned In the posts about $gyre in the last XX hours
$omer, stocks healthcare, alternative investment, $aplm, $sprc, $sora, coins meme, $feam, $codi, abbott laboratories, $abt, aptiv plc, chronic, runner, acquisition, sleeper, $kros, $veri, $tgen, $sana, coins base ecosystem, stocks consumer cyclical, $nvo, $scyx, gsk plc, $qnrx, $ptle, $gwh, $sgbx, market cap, $72752m, news on, stocks utilities, $mp, stocks industrials, stocks financial services, $tic, stocks
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"100new $OMER $VERI $TGEN $SANA $BTDR $SERV $CEPU $PZZA $AIRJ $PHAT $SLN $GYRE $ARRY $OUST $AEVA $ALMU $LEU $ASM $PLPC $ABSI $UEC $ASTL $HI $SSTK $ICHR $MANU $NXT $AQST $BZAI $LTBR $AMPX"
X Link @MammaaiutoY 2025-10-16T08:04Z XXX followers, XXX engagements
"🧬 Biotech Stock News 10/15 Brought to you by Barb On the rise 📈 $OMER XXX% $APLM XX% $SPRC XX% Under pressure 📉 $KROS -X% $EYPT -X% $AKTX -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-15T17:27Z 27.5K followers, 3810 engagements
"$GYRE Gyre Therapeutics shares are trading higher after the company announced it completed patient enrollment in the Phase X clinical trial of Pirfenidone capsules for the treatment of pneumoconiosis"
X Link @stocknear 2025-10-15T16:02Z XXX followers, XXX engagements
"📣 Biotech Stock News 10/15 @ Open $OMER XXX% Asset purchase & license agreement $APLM XX% Resumes Trading $SPRC XX% Acquisition Agreement $ABSI XX% KOL Seminar on ABS-201 Program $XNCR X% Ph1 Dose-Escalation Results Presented $GYRE X% Completion of Patient Enrollment in Trial $SCYX X% Disagreement Resolved on Phase X Study $NVCR X% New Research for TTFields Therapy $HIMS X% Launches Menopause & Perimenopause Specialty $TEM X% Six Abstracts Accepted for ESMO 2025 $MNPR X% Abstract Accepted for Oral Presentation $ACOG X% Presenting Clinical Data at Meetings $AUPH X% Upcoming Presentations on"
X Link @BiopharmIQ 2025-10-15T15:42Z 27.4K followers, 9650 engagements
/topic/$gyre